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ABSTRACT
Murine models are increasingly used for investigations of sleep, yet no previous studies
have characterized cholinergic activation of guanine nucleotide binding proteins (G proteins)
in mouse brainstem nuclei known to regulate sleep. This study used in vitro [35S]guanylyl-
5-O-(-thio)-triphosphate ([35S]GTPS) autoradiography to test the hypothesis that musca-
rinic cholinergic receptors activate G proteins in C57BL/6J (B6) mouse brainstem. The nuclei
studied are homologous to those known in rat and cat to modulate sleep and nociception. In
B6 mouse, carbachol significantly increased specific binding of [35S]GTPS in the pontine
reticular nucleus, caudal part (79%); pontine reticular nucleus, oral part (131%); laterodorsal
tegmental nucleus (56%); pedunculopontine tegmental nucleus (86%); dorsal raphe nucleus
(53%); dorsal medial periaqueductal gray (54%); and ventrolateral periaqueductal gray (52%)
when compared with basal binding. Carbachol-induced G protein activation was
concentration-dependent and blocked by atropine, demonstrating mediation by muscarinic
receptors. G protein activation by carbachol was heterogeneous across B6 mouse brainstem
nuclei. Comparison of [35S]GTPS binding between mouse and rat revealed different mag-
nitudes of G protein activation in the pontine reticular formation. In the same pontine
reticular formation area of B6 mouse where in vitro treatment with carbachol activates G
proteins, in vivo microinjection of cholinomimetics causes a rapid eye movement sleep-like
state. These data provide the first direct measurement of muscarinic receptor-activated G
proteins in B6 mouse brainstem nuclei known in other species to regulate sleep. J. Comp.
Neurol. 457:175–184, 2003. © 2003 Wiley-Liss, Inc.
Indexing terms: GTPS autoradiography; phenotype; pontine reticular formation; laterodorsal
tegmental nucleus; pedunculopontine tegmental nucleus; periaqueductal gray
Most human genes have a mouse homologue (O’Brien et
al., 1999). This homology encourages identification of
mouse genes influencing disease susceptibility and can
point to polymorphisms relevant to human disease (Pai-
gen and Eppig, 2000). Linking successes in mouse genom-
ics to integrative neuroscience will require parallel
progress with proteomic and behavioral phenotyping of
mouse (Paigen and Eppig, 2000). Phenotyping mouse
strains is important for developing a mouse database that
can be compared with other species. Much of the current
progress in neuroscience has come from studies of rat. The
present results provide the first quantitative comparison
of guanine nucleotide binding proteins (G proteins) in
brainstem of rat and mouse. In accord with recommenda-
tions of The Jackson Laboratory’s Mouse Phenome
Project, this study used the C57BL/6J (B6) mouse, as a
strain from which original phenotyping data are needed
(Paigen and Eppig, 2000).
There is good agreement between many laboratories
that brainstem cholinergic neurotransmission contributes
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to sleep cycle control (Aldrich, 1999; Lydic and Bagh-
doyan, 1999; Kryger et al., 2000). Directly administering
cholinergic agonists or acetylcholinesterase inhibitors into
the medial part of cat pontine reticular formation (mPRF)
or the homologous pontine reticular nucleus, oral part
(PnO) of rat causes a concentration-dependent enhance-
ment of rapid eye movement (REM) sleep (reviewed in
Baghdoyan and Lydic, 2002). Acetylcholine (ACh) release
in feline mPRF is significantly greater during REM sleep
than during non-REM sleep and wakefulness (Leonard
and Lydic, 1997). Cholinergic agonists increase REM sleep
by means of muscarinic cholinergic receptors (mAChRs)
coupled to pertussis toxin-sensitive G proteins (Shuman et
al., 1995). The mAChRs modulating REM sleep are likely
to be postsynaptic and of the M2 subtype (Baghdoyan and
Lydic, 1999). Recent studies of intact, unanesthetized
mice show for the first time that a REM sleep-like state is
caused by microinjection of neostigmine into the PnO of
B6 mouse (Lydic et al., 2002). Neostigmine prevents the
enzymatic degradation of ACh. Thus, the ability to cholin-
ergically enhance REM sleep in B6 mouse (Lydic et al.,
2002) is consistent with in vivo microdialysis data show-
ing that endogenously released ACh can be measured in
PnO of B6 mouse (Coleman et al., 2001, 2002).
Cholinergic transmission in brainstem also plays a role
in antinociception. Microinjection of cholinomimetics into
the mPRF of cat (Kshatri et al., 1998) and PnO of rat
(Ishizawa et al., 2000) produces antinociceptive behavior.
In rat PnO, the M2 muscarinic receptor subtype has been
suggested to modulate antinociceptive behavior (Ma et al.,
2001). The mesencephalic periaqueductal gray (PAG) is a
brainstem area known to modulate sleep (Sastre et al.,
1996) and nociception (Reynolds, 1969; Besson and
Chaouch, 1987). Microinjection of cholinergic agonists into
sites throughout the PAG produces antinociceptive behav-
ior (Klamt and Prado, 1991).
The foregoing findings support the view that cell surface
mAChRs and their associated G proteins may be regarded
as a lower level phenotype that modulates higher level
phenotypes such as REM sleep and nociception. No previ-
ous studies have characterized cholinergic activation of G
proteins in mouse brainstem. Therefore, the present study
used in vitro autoradiography to test the hypothesis that
carbachol activates G proteins in the brainstem of B6
mouse. Activated G proteins were assayed by using
[35S]guanylyl-5-O- (-thio)-triphosphate ([35S]GTPS)
binding (Sim et al., 1995, 1997). Seven brainstem nuclei,
known in other mammals to regulate sleep and nocicep-
tion, were selected for quantitative analysis of G protein
activation. Portions of these data have been presented in
abstract form (DeMarco et al., 2001).
MATERIALS AND METHODS
Animals and chemicals
Male B6 mice (22–24 g) were purchased from The Jack-
son Laboratory (Bar Harbor, ME). NEN Life Science Prod-
ucts (Boston, MA) was the source for [35S]GTPS (1,250
Ci/mmol) and Kodak X-OMAT Blue XB-1 autoradiography
film. Sigma Chemical Co. (St. Louis, MO) supplied unla-
beled guanosine 5-(-thio) triphosphate (GTPS),
guanosine 5-diphosphate (GDP), carbachol, and atropine
sulfate.
Preparation of tissue sections
All procedures involving animals were approved by the
University of Michigan Committee on Use and Care of
Animals and conducted in accordance with the Public
Health Service policy on Humane Care and Use of Labo-
ratory Animals (NIH Publication 80-23). Mice were kept
on a 12-hour light/dark cycle with lights on at 6:00 AM and
were decapitated between 9:30 AM and 11:00 AM. Brains
were removed and frozen in a 30°C bilayer of isopentane
and bromobutane. Serial, 20-m coronal sections cut on a
Hacker Bright OTF cryostat (Fairfield, NJ) were thaw-
mounted onto gelatin-coated glass slides with one pair of
adjacent sections per slide. Tissue sections were dried for
2 hours in a cold (5-8°C) vacuum desiccator, then stored at
80°C.
In vitro autoradiography for carbachol-
activated G proteins
The [35S]GTPS binding assay was performed as previ-
ously described (Sim et al., 1995, 1997). Brainstem sections
from a total of 11 mice were sorted sequentially to ensure
that for all mice, each brain region was treated with every
binding condition. Tissue sections were soaked in assay
buffer (50 mM Tris-HCl, 3 mM MgCl2, 100 mM NaCl, and
0.2 mM ethylene glycol tetraacetic acid, pH 7.4 ) for 10
minutes, and preincubated in the same buffer containing 2
mM GDP for 15 minutes. Brainstem sections then were
incubated for 2 hours in a binding bath composed of assay
buffer (pH 7.4) containing 0.04 nM [35S]GTPS and 2 mM
GDP. Tissue sections from eight mice were treated with
either the cholinergic agonist carbachol (1 mM) or carbachol
plus the muscarinic antagonist atropine (0.1 mM). Brain-
stem sections from three mice were incubated with one of
four concentrations of carbachol: 1  107 M, 1  105 M,
1  103 M, and 1  102 M. Basal G protein activation was
assayed by incubating tissue sections without carbachol or
atropine. Nonspecific binding (NSB) was determined by in-
cubation with 10 M unlabeled GTPS in the absence of
carbachol or atropine. After the incubation period, tissue
sections were rinsed twice with ice-cold Tris buffer (pH 7.0)
for 2 minutes and once in ice-cold deionized H2O for 30
seconds. Tissue sections were dried at room temperature,
first with a stream of forced air and then in a vacuum
desiccator overnight. Dry tissue sections were placed in
stainless steel film cassettes with 14C Microscale standards
(Amersham, Arlington Heights, IL; 31-883 nCi/g) and auto-
radiography film. Seventy-two hours later, films were devel-
oped by using a Kodak X-OMAT- 2000A autoprocessor. Hot
(80°C) paraformaldehyde vapor was used to fix the tissue
sections (Herkenham and Pert, 1982), which were then
stained with cresyl violet.
Data collection and analysis
A Northern Light illuminator (Imaging Research, On-
tario, Canada) was used to backlight cresyl violet–stained
tissue sections and the corresponding autoradiograms.
Stained sections and autoradiographic films were digi-
tized by using a Cohu (San Diego, CA) CCD camera con-
nected to an Apple G3 computer by means of a digitizing
card (Data Translations, Marlboro, MA). The Scion Image
(1.62c) program was used to quantify G protein activation
by densitometric analysis of the digitized autoradiograms.
Figure 1 shows autoradiograms from rat and mouse brain-
stem sections treated with carbachol (1 mM). These im-
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ages illustrate the ability to resolve specific reticular fields
and nuclei. The seven brainstem nuclei studied were dor-
somedial periaqueductal gray (DMPAG), dorsal raphe nu-
cleus (DR), pedunculopontine tegmental nucleus (PPT),
pontine reticular nucleus (caudal part, PnC), pontine re-
ticular nucleus (oral part, PnO), laterodorsal tegmental
nucleus (LDT), and ventrolateral periaqueductal gray
(VLPAG). Mouse brainstem nuclei were localized on the
cresyl violet–stained sections according to the mouse
brain atlas (Franklin and Paxinos, 1997). Rat PAG nuclei
were localized according to the rat brain atlas (Paxinos
and Watson, 1999). The anatomic limits of each nucleus
were outlined on the digitized, cresyl violet–stained sec-
tion. The outline then was superimposed onto the corre-
sponding autoradiographic image to ensure accurate lo-
calization of each nucleus. Optical density measurements
of total binding were obtained from each tissue section.
Specific [35S]GTPS binding values were calculated by
subtracting mean NSB values for each brainstem nucleus
from the total binding values for that nucleus.
Data from mouse were analyzed by a mixed effects
model analysis of variance (ANOVA) for repeated mea-
sures and post hoc Tukey’s multiple comparison test (P 
0.05) using SAS (release 8.8, SAS Institute, Inc., Cary,
NC). The numerator degrees of freedom (df) equals the
number of conditions minus 1, and the denominator de-
grees of freedom equals the numerator df multiplied by
the number of animals used per nuclei minus 1. In in-
stances where unequal numbers of animals were used, the
SAS program decreases the degrees of freedom accord-
ingly. Data from rat PAG were collected previously
(Capece et al., 1998a) and analyzed for the present study
by ANOVA. For both rat and mouse, the number of mea-
surements obtained for a given nucleus depended on the
Fig. 1. Autoradiograms showing G protein activation in brain-
stem. Coronal sections compare carbachol-stimulated G protein acti-
vation in rat (left column) and mouse (right column). A, B: From rat
contain nuclei homologous to nuclei present in C and D from mouse.
Relative to bregma in the rat atlas (Paxinos and Watson, 1999), A
corresponds to 9.30 and B to 7.64. Relative to bregma in the mouse
atlas (Franklin and Paxinos, 1997), C corresponds to 5.40 and D to
4.48. Scale bar  1 mm.
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anterior-to-posterior extent of the nucleus and whether or
not the nucleus was bilaterally symmetrical. For example,
because mouse PnC spans from bregma 5.02 to 5.68
and is bilaterally symmetrical, the quantitative data in-
cluded approximately 12 measurements per mouse per
treatment condition. For mouse DR, which ranges from
bregma 4.04 to 4.36 and is a midline structure, mea-
surements consisted of approximately five values per
mouse per treatment condition.
RESULTS
Figure 2 uses color-coded images of autoradiograms to
illustrate total [35S]GTPS binding. Basal levels of
[35S]GTPS binding were relatively low and heteroge-
neous (Fig. 2, top row). Carbachol (1 mM) activated G
proteins throughout the brainstem (Fig. 2, middle row),
and atropine blocked carbachol-stimulated [35S]GTPS
binding (Fig. 2, bottom row). The images in Figure 2 are
from a single mouse and are representative of the group
data.
Figure 3A quantifies specific [35S]GTPS binding in
seven nuclei of mouse brainstem. For all nuclei studied,
carbachol (1 mM) significantly increased G protein activa-
tion above basal levels, and atropine (0.1 mM) reduced
carbachol-stimulated G protein activity to basal levels.
The Figure 3A data represent 1,049 measurements from
eight mice for VLPAG, DMPAG, DR, PnO, and PnC, 155
measurements from six mice for PPT, and 124 measure-
ments from four mice for LDT. Power analysis indicated
that four animals yielded a sufficient sample size for sta-
tistical analysis of LDT. ANOVA revealed a significant
effect of treatment condition in VLPAG (F(2,14)  65.02;
P  0.001), DMPAG (F(2,14)  80.2; P  0.001), DR
(F(2,14)  137.14; P  0.001), LDT (F(2,6)  74.9; P 
0.001), PPT (F(2,10)  63.5; P  0.001), PnO (F(2,14) 
121.43; P  0.001), and PnC (F(2,14)  71.47; P  0.001).
Although sleep-related brainstem nuclei have been
studied in rat with respect to cholinergic activation of G
proteins (Capece et al., 1998a), no previous studies have
demonstrated cholinergic activation of G proteins in rat
PAG. Figure 3B illustrates G protein activation quantified
for DMPAG and VLPAG of rat. These data represent 264
measurements from six rats. Carbachol (1 mM) signifi-
cantly increased specific [35S]GTPS binding in DMPAG
(F(2,15)  14.7; P  0.001) and VLPAG (F(2,15)  19.2; P 
0.001). Atropine (0.1 mM) returned carbachol-stimulated
[35S]GTPS binding to basal levels.
This study next sought to determine whether car-
bachol-induced G protein activation was concentration-
dependent and could be saturated. The autoradiograms in
Figure 4A demonstrate the concentration response for
carbachol-stimulated [35S]GTPS binding in mouse brain-
stem. Increases in [35S]GTPS binding corresponding to G
protein activation are apparent at carbachol concentra-
tions greater than 1  107 M. These images are repre-
sentative of those used to obtain quantitative
concentration-response data. Figure 4B shows represen-
tative autoradiograms of the concentration response for
carbachol-stimulated [35S]GTPS binding in rat brain-
stem. Similar to autoradiograms from mouse, the Figure 4B
rat autoradiograms show increases in [35S]GTPS binding
at carbachol concentrations greater than 1  107 M.
Figure 5A shows that, in mouse brainstem, car-
bachol-induced [35S]GTPS binding was concentration-
dependent and could be saturated. Due to the small size of
the mouse brainstem and the need to test each concentra-
tion of carbachol in tissue sections from the same mouse,
two brainstem regions with relatively long rostral-to-
caudal extents were selected for concentration–response
analysis. These were the pontine reticular formation
(PRF) and the PAG. The PRF was defined to include PnO
and PnC, and the PAG was defined to include VLPAG and
DMPAG. The Figure 3A data showed that there was no
significant difference in [35S]GTPS binding between PnO
and PnC for any treatment condition, providing a ratio-
nale for combining measures from these nuclei. Similarly,
there was no difference in G protein activation between
VLPAG and DMPAG (Fig. 3A), and measures from these
two areas were combined for the concentration–response
analysis. The Figure 5A data summarize 376 measure-
ments obtained from three mice. ANOVA revealed a sig-
nificant effect of carbachol concentration in PRF (F(4,8) 
16.43; P  0.0006) and PAG (F(4,8)  29.06; P  0.0001).
Post hoc Tukey’s analysis demonstrated that G protein
activation in the PRF was significantly increased over
basal values by 103 M (1 mM) and 102 M (10 mM)
carbachol. In mouse PAG, G protein activation was signif-
icantly increased over basal values by 105 M (0.01 mM),
103 M (1 mM), and 102 M (10 mM) carbachol.
Figure 5B demonstrates that, in rat PAG, car-
bachol-induced [35S]GTPS binding was concentration-
dependent and could be saturated. As with mouse, there
was no significant difference in [35S]GTPS binding be-
tween VLPAG and DMPAG (Fig. 3B). Therefore, Figure
5B combines measures from VLPAG and DMPAG as a
function of carbachol concentration. The Figure 5B data
were obtained from 339 measurements in three rat brains.
ANOVA revealed a significant effect of carbachol concen-
tration on [35S]GTPS binding in PAG. G protein activa-
tion by 1 mM carbachol was significantly greater than
basal values.
Figure 6 compares carbachol-stimulated G protein acti-
vation as a percentage of basal [35S]GTPS binding be-
tween mouse and rat for five brainstem regions. ANOVA
indicated a statistically significant region main effect for
carbachol-stimulated [35S]GTPS binding in mouse
(F(6,36)  63.86; P  0.0001) and rat (F(6,30) 142.9; P 
0.0001). The greatest increase over basal [35S]GTPS
binding was in PRF (105%) for mouse and LDT (75%) for
rat. The lowest percentage increase over basal binding
was found in DR and PAG (53%) for mouse and PAG (43%)
for rat. Student’s t-test revealed statistically significant
differences in G protein activation between mouse PRF
and rat PRF.
DISCUSSION
The present data demonstrate, for the first time, cholin-
ergically mediated G protein activation in brainstem
nuclei of B6 mouse. Stimulation of G proteins by car-
bachol was heterogeneous across nuclei, concentration-
dependent, and blocked by atropine. This study also pro-
vides the first comparison of cholinergically induced G
protein activation between specific brainstem nuclei of
mouse and rat. Data were obtained by using in vitro
[35S]GTPS autoradiography to visualize and quantify G
protein activation. This assay is unique in permitting
precise anatomic localization of activated G proteins (Figs.
1, 2, 4) and quantification of specific [35S]GTPS binding
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Fig. 2. G protein activation in mouse brainstem. Color-coded au-
toradiograms of coronal sections show total [35S]guanylyl-5-O-(-
thio)-triphosphate ([35S]GTPS) binding for three treatment condi-
tions (rows) at two brainstem levels (columns). Locations of the seven
nuclei studied are indicated for each section. Note that the sections
treated simultaneously with carbachol (1 mM) and atropine (0.1 mM)
showed levels of G protein activation similar to basal, indicating that
the carbachol-stimulated increases in [35S]GTPS binding resulted
from activation of muscarinic receptors. Scale bar  1 mm.
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mouse and rat brainstem was mediated by
muscarinic cholinergic receptors
Two criteria must be met to demonstrate that a process
is receptor mediated. One is the blocking of ligand action
by a receptor antagonist. The second criterion is a
concentration-response that saturates. The present data
satisfy both criteria.
Atropine is a competitive inhibitor of mAChRs, and
atropine blocked carbachol-stimulated G protein activa-
tion in mouse (Figs. 2, 3A) and rat (Fig. 3B). This finding
supports the conclusion that carbachol-induced G protein
activation in mouse brainstem and rat PAG is mediated by
mAChRs. The present G protein data are congruent with
data showing that atropine blocks carbachol-stimulated
[35S]GTPS binding in cortical membranes from human
brain (Gonzalez-Maeso et al., 2000) and in REM sleep-
related brainstem nuclei of rat (Capece et al., 1998b). The
present results are consistent with in vivo data demon-
strating that muscarinic antagonists inhibit cholinergi-
cally induced REM sleep in cat (Baghdoyan et al., 1984;
Velazquez-Moctezuma et al., 1990; Baghdoyan and Lydic,
1999) and rat (Imeri et al., 1994; Bourgin et al., 1995).
G protein activation was concentration-dependent in
mouse pontine reticular formation and mouse and rat
periaqueductal gray (Fig. 5). The concentration–response
curves for PRF and PAG also exhibited saturation, consis-
tent with a receptor mediated process. These findings
parallel previously reported concentration–response
curves for carbachol-stimulated [35S]GTPS binding in
chick optic tectum (Kurkinen et al., 1997) and rat PRF
(Capece et al., 1998a). Studies microinjecting cholinomi-
metics into the PRF in vivo have demonstrated the
concentration-dependent nature of cholinergically en-
hanced REM sleep in cat (Baghdoyan et al., 1984, 1989)
and rat (Bourgin et al., 1995).
Comparison of carbachol-stimulated
G protein activation in rat
and mouse brainstem
Activation of G proteins by carbachol was not signifi-
cantly different between the PnC and PnO regions of
mouse pontine reticular formation (Fig. 3A). In mouse
(Fig. 3A) and rat (Fig. 3B), G protein activation was not
different between the DMPAG and VLPAG regions of the
periaqueductal gray. In both mouse and rat, activation of
G proteins by carbachol was heterogeneous across the
other nuclei studied. In mouse, the largest percentage
change from basal activation was noted in the PRF,
whereas in rat, the largest change was noted in the LDT
(Fig. 6). The lowest percentage change from basal activa-
tion for both species was seen in DR and PAG. These
findings are consistent with other comparative studies of
mouse and rat. For example, the distribution of galanin-
ergic immunoreactivity in mouse brain is similar to that of
rat in most areas but is significantly different in the ol-
factory bulb, thalamus, pretectum, and medulla (Perez et
al., 2001). Cholinergic innervation as measured by choline
acetyltransferase activity is similar in mouse and rat cor-
pus striatum, thalamus, basal forebrain, and pons, but
significantly different in the neocortex (Owasoyo and
Olowookorun, 1982; Gordon and Finch, 1984; Kitt et al.,
1994). Statistically significant differences were noted be-
tween carbachol-stimulated [35S]GTPS binding in mouse
and rat PRF (Fig. 6).
Functional implications
Carbachol was chosen as the agonist to activate
receptor-coupled G proteins because of the good consensus
that brainstem ACh significantly modulates electroen-
cephalographic and behavioral arousal (Lydic and Bagh-
doyan, 1998, 1999; Aldrich, 1999; Kryger et al., 2000). The
present functional neuroanatomic data can be related to
in vivo pharmacologic data regarding the cholinergic mod-
ulation of REM sleep. Microinjection of cholinomimetics
into feline PRF regions homologous to mouse PRF causes
REM sleep to increase by several hundred percent (Bagh-
doyan and Lydic, 1999). Similar microinjections into ho-
mologous PRF regions of rat either failed to consistently

































































































Fig. 3. Carbachol-stimulated [35S]guanylyl-5-O-(-thio)-
triphosphate ([35S]GTPS) binding in mouse and rat brainstem.
A: Quantitative analysis revealed that, in mouse, carbachol caused G
protein activation, and atropine blocked the carbachol-induced acti-
vation in each of the seven nuclei studied. These data demonstrate
that G protein activation was mediated by muscarinic receptors.
Asterisks indicate significant increases in G protein activation over
respective basal and carbachol  atropine levels (P  0.0001). B: Car-
bachol activated G proteins in rat dorsomedial (DMPAG) and ventro-
lateral (VLPAG) periaqueductal gray. Carbachol activation of G pro-
teins was blocked by atropine, indicating mediation by muscarinic
cholinergic receptors. Asterisks indicate significant increases in G
protein activation over respective basal and carbachol  atropine
levels (P  0.01).
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Fig. 4. Autoradiograms from mouse and rat brainstem illustrate a
concentration-dependent increase in G protein activation caused by
carbachol. Autoradiograms show sequential sections from caudal
(basal) to rostral. Carbachol concentration ranged from 1  107 M
(top) to 1  102 M (bottom). A: These coronal sections from the same
mouse brain extend from bregma 4.60 (top) to 4.24 (bottom)
(Franklin and Paxinos, 1997). B: Sequential coronal sections from the
same rat brainstem span from bregma 8.00 (top) to 7.64 (bottom;
Paxinos and Watson, 1999). Scale bar  1 mm.
increase REM sleep (Deurveilher et al., 1997) or increased
REM sleep by approximately 50% (Bourgin et al., 1995).
Thus, there are important species differences between cat
and rat with respect to cholinergic triggering of REM
sleep.
Microinjection data from rat also indicate that cholin-
ergic stimulation of PnC is significantly less efficacious in
causing REM sleep enhancement than cholinergic stimu-
lation of PnO (Bourgin et al., 1995). These functional data
can be contrasted with the observations of no significant
difference in cholinergic activation of G proteins between
PnO and PnC of mouse (Fig. 3A) or rat (Capece et al.,
1998a). Similarly, there is a homogeneous distribution of
mAChRs across PnO and PnC of rat (Baghdoyan, 1997).
Thus, the REM sleep-enhancing actions of carbachol are
significantly greater in rat PnO than PnC (Bourgin et al.,
1995) in the absence of significant differences between
PnO and PnC in density of mAChRs (Baghdoyan, 1997) or
cholinergically activated G proteins (Capece et al., 1998a).
Figure 6 shows that the same concentration of carbachol
caused significantly greater G protein activation in mouse
PRF than in rat PRF. One function of G proteins is am-
plification of transmembrane signaling, and the Figure 6
data suggest that REM sleep in mouse also will be in-
creased by pontine administration of cholinomimetics.
This implication is supported by three new findings. First,
PnO microinjection of the acetylcholinesterase inhibitor
neostigmine causes REM sleep enhancement in B6 mouse
(Lydic et al., 2002). Second, the cholinergic agonist carba-
chol also increases REM sleep when microinjected into
PnO of B6 mouse (Fig. 7). Third, microdialysis data show
that endogenous ACh is released in PnO of B6 mouse
(Coleman et al., 2001, 2002).
In rat periaqueductal gray, microinjection of carbachol
causes antinociception (Guimaraes et al., 2000). The
present data show that, in mouse and rat periaqueductal
gray, G proteins were activated by carbachol (Figs. 2, 3, 5).
Considered together, these data suggest that microinjec-
tion of cholinergic agonists into periaqueductal gray of B6
mouse will cause antinociception. This speculation is open
to future investigation.
Limitations and conclusions
The [35S]GTPS assay provides novel information re-
garding the distribution of signal transduction pathways













































































































Fig. 5. Concentration–response curves for specific [35S]guanylyl-
5-O-(-thio)-triphosphate ([35S]GTPS) binding. A: Carbachol caused
a concentration-dependent increase in G protein activation in the
pontine reticular formation (PRF) and periaqueductal gray (PAG) of
mouse. Asterisks and crosses indicate significant increases in G pro-
tein activation over respective basal values (P  0.01). B: In the
periaqueductal gray (PAG) of rat, carbachol caused a concentration-
dependent increase in G protein activation. The asterisk indicates a
significant increase in G protein activation over basal (P  0.05).
Mouse and rat data are consistent with the conclusion that carbachol-
stimulated G protein activation is receptor mediated.




























































Fig. 6. Comparison of carbachol-stimulated [35S]guanylyl-5-O-(-
thio)-triphosphate ([35S]GTPS) binding in mouse and rat brainstem.
G protein activation by 1 mM carbachol was heterogeneous across
nuclei in both mouse and rat. G protein activation was significantly
greater in mouse pontine reticular formation (PRF) than in rat PRF
(*P  0.05). Rat data for PRF, pedunculopontine tegmental nucleus
(PPT), laterodorsal tegmental nucleus (LDT), and dorsal raphe nu-
cleus (DR) are from (Capece et al., 1998a).
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[35S]GTPS assay have been discussed previously (Sim et
al., 1995, 1997), it should be noted in the context of the
present study that the assay does not resolve the specific
subtypes of activated G proteins. The assay has been
suggested to favor activation of inhibitory G proteins
(Kurkinen et al., 1997). In addition, in vitro stimulation of
G proteins by carbachol may not parallel in vivo activation
of G proteins by ACh.
In conclusion, this study is the first to quantify cholin-
ergically activated G proteins in brainstem nuclei of B6
mouse that are known to regulate sleep-induced alter-
ations in arousal and nociception. The present results also
provide the first comparison of cholinergically activated G
proteins in rat and mouse brainstem. These comparative
data are in agreement with data demonstrating that cho-
linergically activated [35S]GTPS binding is concen-
tration-dependent and blocked by muscarinic antagonists
(Kurkinen et al., 1997; Capece et al., 1998a). Sleep is a
heritable phenotype in humans (Katzenberg et al., 1998;
Toh et al., 2001), and sleep varies significantly as a func-
tion of mouse strain (Franken et al., 1998; Huber et al.,
2000). Applying the power of mouse genetics to sleep neu-
robiology will require establishing causal links between
genes regulating lower level phenotypes such as G pro-
teins and higher level phenotypes such as sleep.
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